Virscio
Robert T. Davis III is an accomplished Senior Research Scientist and Study Director at Virscio, where responsibilities include managing GLP and non-GLP studies and contributing to internal research in cardiovascular, metabolic, and respiratory diseases since January 2021. Prior experience includes serving as a Study Director at Covance, overseeing client-sponsored studies and ensuring compliance with regulatory requirements from June 2018 to January 2021, and as a Senior Scientist at Pfizer from July 2016 to June 2018, where focus was on drug target validation and assay development. Earlier roles include a Postdoctoral Research Fellow at the University of Illinois at Chicago, developing in-vivo and in-vitro models for studying cardiovascular physiology, and a PhD candidacy at the University of Florida, which established a strong foundational expertise in the field.
This person is not in any teams
This person is not in any offices
Virscio
1 followers
Virscio is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the pharmaceutical and life sciences industry. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of sponsors, collaborators, and partners around the world, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most efficient and robust manner.